Yokoyama Takanori, Okame Shinichi, Okazawa-Sakai Mika, Fujimoto Etsuko, Hibino Yumi, Teramoto Norihiro, Takehara Kazuhiro
Department of Gynecologic Oncology, National Hospital Organization (NHO) Shikoku Cancer Center, Ko-160 Minami-Umemoto, Matsuyama, 7910280, Japan.
Department of Cancer Genomic Medicine, National Hospital Organization (NHO) Shikoku Cancer Center, Ko-160 Minami-Umemoto, Matsuyama, 7910280, Japan.
Sci Rep. 2025 Jan 18;15(1):2365. doi: 10.1038/s41598-025-86784-4.
Cancer cells in the right subdiaphragmatic lavage may reflect peritoneal dissemination, but its prognostic significance is unknown. This study investigated recurrence-free survival (RFS), overall survival (OS), and recurrence patterns in patients with curatively resected endometrial cancer by cytology collection site. Peritoneal cytology was collected at the beginning of surgery by washing the pelvic and right subdiaphragmatic cavity separately. The analysis included 465 patients with the median follow-up duration of 121 months. Of these, 62 (13%) patients had positive pelvic cytology and 22 (5%) patients had positive right subdiaphragmatic cytology. Patients positive for right subdiaphragmatic cytology were all positive for pelvic cytology, showing the worst RFS and OS among the study population. Multivariate analyses showed positive right subdiaphragmatic cytology, not pelvic cytology, significantly correlated with shorter RFS and OS when adjusted for clinicopathological factors. Patients with both pelvic and right subdiaphragmatic positive cytology had significantly higher peritoneal recurrence rates than those negative at both sites. However, patients with only positive pelvic cytology showed no significant difference in the recurrence rate. Our results suggest that the prognostic significance of peritoneal cytology may differ depending on the collection site in endometrial cancer and provide new insights to select patients for adjuvant therapy.
右膈下灌洗中的癌细胞可能反映腹膜播散,但其预后意义尚不清楚。本研究按细胞学采集部位调查了接受根治性切除的子宫内膜癌患者的无复发生存期(RFS)、总生存期(OS)和复发模式。手术开始时,分别冲洗盆腔和右膈下腔以采集腹膜细胞学样本。分析纳入了465例患者,中位随访时间为121个月。其中,62例(13%)患者盆腔细胞学检查呈阳性,22例(5%)患者右膈下细胞学检查呈阳性。右膈下细胞学检查呈阳性的患者盆腔细胞学检查均为阳性,在研究人群中显示出最差的RFS和OS。多因素分析显示,在调整临床病理因素后,右膈下细胞学检查阳性而非盆腔细胞学检查阳性与较短的RFS和OS显著相关。盆腔和右膈下细胞学检查均为阳性的患者腹膜复发率明显高于两处均为阴性的患者。然而,仅盆腔细胞学检查呈阳性的患者复发率无显著差异。我们的结果表明,腹膜细胞学检查的预后意义可能因子宫内膜癌的采集部位而异,并为选择辅助治疗的患者提供了新的见解。